Systochem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 4.41 M
as on 15-12-2024
- Company Age 29 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.78 Cr
as on 15-12-2024
- Satisfied Charges ₹ 2.99 Cr
as on 15-12-2024
- Revenue 47.88%
(FY 2022)
- Profit 72.33%
(FY 2022)
- Ebitda 15.37%
(FY 2022)
- Net Worth 26.24%
(FY 2022)
- Total Assets 39.99%
(FY 2022)
About Systochem Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.41 M.
The company currently has active open charges totaling ₹9.78 Cr. The company has closed loans amounting to ₹2.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajender Bansal, Sukh Garg, and Sagar Garg serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PLC074124
- Company No.
074124
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Nov 1995
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Systochem Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajender Bansal  | Director | 29-Sep-2002 | Current |
| Sukh Garg | Director | 25-Nov-1995 | Current |
| Sagar Garg | Director | 01-Jul-2016 | Current |
Financial Performance and Corporate Structure Insights of Systochem Laboratories.
Systochem Laboratories Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.88% increase. The company also saw a substantial improvement in profitability, with a 72.33% increase in profit. The company's net worth Soared by an impressive increase of 26.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Systochem Laboratories?
In 2023, Systochem Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Jun 2022 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 22 Jul 2021 | ₹0.80 M | Open |
Hdfc Bank Limited Creation Date: 03 Nov 2015 | ₹4.75 Cr | Open |
How Many Employees Work at Systochem Laboratories?
Systochem Laboratories has a workforce of 30 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Systochem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Systochem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
